Fluoxetine is a safer alternative to fenfluramine in the medical treatment of obesity

被引：9

作者：

Anchors, M

机构：

来源：

ARCHIVES OF INTERNAL MEDICINE | 1997年 / 157卷 / 11期

关键词：

D O I：

10.1001/archinte.157.11.1270

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1270 / 1270

页数：1

共 4 条

[1] Appetite-suppressant drugs and the risk of primary pulmonary hypertension [J].

Abenhaim, L ;

Moride, Y ;

Brenot, F ;

Rich, S ;

Benichou, J ;

Kurz, X ;

Higenbottam, T ;

Oakley, C ;

Wouters, E ;

Aubier, M ;

Simonneau, G ;

Begaud, B .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (09) :609-616

[2]

ATKINSON RC, 1993, OBEST RES S, V1, P204

[3] INCREASED PLASMA SEROTONIN IN PRIMARY PULMONARY-HYPERTENSION [J].

HERVE, P ;

LAUNAY, JM ;

SCROBOHACI, ML ;

BRENOT, F ;

SIMONNEAU, G ;

PETITPRETZ, P ;

POUBEAU, P ;

CERRINA, J ;

DUROUX, P ;

DROUET, L .

AMERICAN JOURNAL OF MEDICINE, 1995, 99 (03) :249-254

[4] LONG-TERM WEIGHT CONTROL - THE NATIONAL-HEART-LUNG-AND-BLOOD-INSTITUTE FUNDED MULTIMODAL INTERVENTION STUDY - INTRODUCTION [J].

WEINTRAUB, M .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (05) :581-585

← 1 →